Haoxi Health Technology Limited

 

June 13, 2024

 

Via EDGAR

 

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

 

Attention:	Robert Shapiro
	Doug Jones
	Nicholas Nalbantian
	Erin Jaskot

  

Re:	Haoxi Health Technology Limited
	Registration Statement on Form F-1, as amended
	Initially Filed on June 13, 2024
	File No. 333-280174

 

Ladies and Gentlemen:

 

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration Statement become effective at 4:30 p.m., Eastern Time, on June 17, 2024, or as soon thereafter as practicable.

 

	Very truly yours,
	Haoxi Health Technology Limited
	By:	/s/ Fan Zhen
		Name:	Fan Zhen
		Title:	Chief Executive Officer, Director